NM_000377.3:c.16A>G

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_000377.3(WAS):​c.16A>G​(p.Met6Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,209,536 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., 1 hem., cov: 22)
Exomes 𝑓: 0.000011 ( 0 hom. 6 hem. )

Consequence

WAS
NM_000377.3 missense

Scores

1
2
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 0.407

Publications

1 publications found
Variant links:
Genes affected
WAS (HGNC:12731): (WASP actin nucleation promoting factor) The Wiskott-Aldrich syndrome (WAS) family of proteins share similar domain structure, and are involved in transduction of signals from receptors on the cell surface to the actin cytoskeleton. The presence of a number of different motifs suggests that they are regulated by a number of different stimuli, and interact with multiple proteins. Recent studies have demonstrated that these proteins, directly or indirectly, associate with the small GTPase, Cdc42, known to regulate formation of actin filaments, and the cytoskeletal organizing complex, Arp2/3. Wiskott-Aldrich syndrome is a rare, inherited, X-linked, recessive disease characterized by immune dysregulation and microthrombocytopenia, and is caused by mutations in the WAS gene. The WAS gene product is a cytoplasmic protein, expressed exclusively in hematopoietic cells, which show signalling and cytoskeletal abnormalities in WAS patients. A transcript variant arising as a result of alternative promoter usage, and containing a different 5' UTR sequence, has been described, however, its full-length nature is not known. [provided by RefSeq, Jul 2008]
WAS Gene-Disease associations (from GenCC):
  • Wiskott-Aldrich syndrome
    Inheritance: XL, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Ambry Genetics
  • X-linked severe congenital neutropenia
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • thrombocytopenia 1
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.08142796).
BP6
Variant X-48683869-A-G is Benign according to our data. Variant chrX-48683869-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 1685211.
BS2
High AC in GnomAdExome4 at 12 XL,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000377.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WAS
NM_000377.3
MANE Select
c.16A>Gp.Met6Val
missense
Exon 1 of 12NP_000368.1P42768
WAS
NM_001438877.1
c.16A>Gp.Met6Val
missense
Exon 1 of 12NP_001425806.1
WAS
NM_001438878.1
c.16A>Gp.Met6Val
missense
Exon 1 of 12NP_001425807.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WAS
ENST00000376701.5
TSL:1 MANE Select
c.16A>Gp.Met6Val
missense
Exon 1 of 12ENSP00000365891.4P42768
WAS
ENST00000698635.1
c.16A>Gp.Met6Val
missense
Exon 1 of 12ENSP00000513850.1A0A8V8TM35
WAS
ENST00000698626.1
c.16A>Gp.Met6Val
missense
Exon 1 of 13ENSP00000513845.1A0A8V8TNH9

Frequencies

GnomAD3 genomes
AF:
0.0000269
AC:
3
AN:
111481
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000566
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000437
AC:
8
AN:
183053
AF XY:
0.0000592
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000125
Gnomad NFE exome
AF:
0.0000367
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000109
AC:
12
AN:
1098000
Hom.:
0
Cov.:
31
AF XY:
0.0000165
AC XY:
6
AN XY:
363366
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26399
American (AMR)
AF:
0.00
AC:
0
AN:
35196
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19374
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30197
South Asian (SAS)
AF:
0.000148
AC:
8
AN:
54127
European-Finnish (FIN)
AF:
0.0000247
AC:
1
AN:
40521
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4135
European-Non Finnish (NFE)
AF:
0.00000356
AC:
3
AN:
841974
Other (OTH)
AF:
0.00
AC:
0
AN:
46077
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000269
AC:
3
AN:
111536
Hom.:
0
Cov.:
22
AF XY:
0.0000296
AC XY:
1
AN XY:
33734
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30745
American (AMR)
AF:
0.00
AC:
0
AN:
10525
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2652
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3505
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2656
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6080
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.0000566
AC:
3
AN:
52961
Other (OTH)
AF:
0.00
AC:
0
AN:
1514
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.0000659
AC:
8

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not specified (1)
-
-
1
Wiskott-Aldrich syndrome;C1839163:Thrombocytopenia 1;C1845987:X-linked severe congenital neutropenia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.038
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.17
CADD
Benign
0.93
DANN
Benign
0.88
DEOGEN2
Benign
0.011
T
FATHMM_MKL
Benign
0.067
N
LIST_S2
Benign
0.38
T
M_CAP
Pathogenic
0.72
D
MetaRNN
Benign
0.081
T
MetaSVM
Uncertain
0.78
D
MutationAssessor
Benign
-0.92
N
PhyloP100
0.41
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.75
N
REVEL
Uncertain
0.44
Sift
Benign
0.32
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.065
MutPred
0.33
Loss of MoRF binding (P = 0.1254)
MVP
0.84
MPC
0.59
ClinPred
0.010
T
GERP RS
2.4
PromoterAI
0.14
Neutral
Varity_R
0.10
gMVP
0.61
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs782730988; hg19: chrX-48542258; API